Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations

ABSTRACTObjective: Varenicline, a selective partial agonist of the α4β2 nicotinic acetylcholine receptor, is a smoking cessation pharmacotherapy that more than doubles the chance of quitting smokin...